100 related articles for article (PubMed ID: 1684016)
21. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
Castaigne S
Soins; 1990; (538-539):24-6. PubMed ID: 2237532
[No Abstract] [Full Text] [Related]
22. Retinoic acids in the treatment of acute promyelocytic leukemia.
Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
[TBL] [Abstract][Full Text] [Related]
23. [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia].
Degos L
Presse Med; 1990 Oct; 19(32):1483-4. PubMed ID: 2146649
[No Abstract] [Full Text] [Related]
24. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
[No Abstract] [Full Text] [Related]
25. Filgrastim combined with tretinoin in acute promyelocytic leukaemia.
Usuki K; Ikeda Y; Kitazume K; Iwabe K; Okuyama Y; Urabe A
Lancet; 1994 Mar; 343(8900):803-4. PubMed ID: 7510817
[No Abstract] [Full Text] [Related]
26. Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia.
Frankel SR; Miller WH; Dmitrovsky E
Oncology (Williston Park); 1992 Aug; 6(8):74-78, 83; discussion 84, 87-8. PubMed ID: 1323988
[TBL] [Abstract][Full Text] [Related]
27. [All-trans-retinoic acid in the treatment of promyelocytic leukemia].
Nousiainen T; Jantunen E
Duodecim; 1993; 109(16):1410-4. PubMed ID: 7720600
[No Abstract] [Full Text] [Related]
28. Retinoic acid therapy for promyelocytic leukaemia.
Chomienne C; Ballerini P; Balitrand N; Amar M; Bernard JF; Boivin P; Daniel MT; Berger R; Castaigne S; Degos L
Lancet; 1989 Sep; 2(8665):746-7. PubMed ID: 2570995
[No Abstract] [Full Text] [Related]
29. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia.
Gillis S; Blaszkowsky LS
Blood; 1995 Aug; 86(4):1644-5. PubMed ID: 7632976
[No Abstract] [Full Text] [Related]
30. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Asou N
Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
[No Abstract] [Full Text] [Related]
31. All-trans-retinoic acid in acute promyelocytic leukemia.
Sanz MA; Martín G; Díaz-Mediavilla J
N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
[No Abstract] [Full Text] [Related]
32. All-trans-retinoic acid in acute promyelocytic leukemia: let's get on with finding out how good it is.
Gallagher RE
J Clin Oncol; 1993 Mar; 11(3):589-90. PubMed ID: 8445438
[No Abstract] [Full Text] [Related]
33. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
34. History of promyelocytic leukaemia.
Bernard J
Leukemia; 1994; 8 Suppl 2():S1-5. PubMed ID: 7815829
[TBL] [Abstract][Full Text] [Related]
35. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
Gillis JC; Goa KL
Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
[TBL] [Abstract][Full Text] [Related]
36. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
Stentoft J; Nielsen JL; Hvidman LE
Leukemia; 1994; 8 Suppl 2():S77-80. PubMed ID: 7815844
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
Degos L
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
[TBL] [Abstract][Full Text] [Related]
38. All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia.
Simone MD; Stasi R; Venditti A; Del Poeta G; Aronica G; Bruno A; Masi M; Tribalto M; Papa G; Amadori S
Leukemia; 1995 Aug; 9(8):1412-3. PubMed ID: 7643633
[No Abstract] [Full Text] [Related]
39. Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day.
Lemez P
Eur J Haematol; 1995 Oct; 55(4):275-6. PubMed ID: 7589349
[No Abstract] [Full Text] [Related]
40. Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
Breccia M; Latagliata R; Carmosino I; Cannella L; Diverio D; Guarini A; De Propris MS; Petti MC; Avvisati G; Cimino G; Mandelli F; Lo-Coco F
Haematologica; 2008 Dec; 93(12):1918-20. PubMed ID: 18945746
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
